Skip to content
10-K

Annual Report

BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH

0001091818-25-000036

← back to feed
Filed
Apr 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Apr 7, 2025 33.52M sh
Shares Diluted FY 2024 · Dec 31, 2023 29.27M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$46.7K
Cash And Equivalents FY 2024 · Dec 31, 2023 $638
Current Liabilities FY 2024 · Dec 31, 2023 $1.82M
Total Liabilities FY 2024 · Dec 31, 2023 $1.82M
Current Assets FY 2024 · Dec 31, 2023 $638
Total Assets FY 2024 · Dec 31, 2023 $638
Eps Diluted FY 2024 · Dec 31, 2023 −$0.02
Eps Basic FY 2024 · Dec 31, 2023 −$0.02
Sga Expense FY 2024 · Dec 31, 2023 $48.95K
Net Income FY 2024 · Dec 31, 2023 −$471.95K
Stockholders Equity FY 2024 · Dec 31, 2022 −$1.35M